Categories
Pages
-

SmartMedCN

Schlagwort: ‘Pricing’

Hainan: supervising the drug procurement process

January 18th, 2021 | by

On October 10th, the Hainan Medical Insurance Bureau issued the “Plan on Supervising and Evaluating the Medical Price in Hainan Province.” The “Plan” clarifies that drugs included in the procurement list on the website of the centralised procurement platform of Hainan Province should be supervised, which means that monitoring and early warning systems will be implemented as drugs are published on or removed from the website as well as during the processes of drug procurement, distribution, use, and purchase. In addition, a centralised drug procurement assessment for medical institutions should be developed, in which will be evaluated particularly whether medical institutions have obeyed the purchase agreement and paid for the drugs with in 30 days, the rate of drug cost compared with the whole medical costs in medical institutions, the rate and purchasement of unselected drugs, and illegal purchase behavior.

医保局推药品采购全流程监测预警!严抓30天回款率

来源医药网  2020.10.12

10月10日,海南省医疗保障局印发《海南省医药价格综合监管评价服务工作方案》(以下称《工作方案》)。《工作方案》明确,将在海南省医药集中采购平台挂网采购的药品纳入监测内容,对药品的挂网、撤网、采购、配送、使用和回款等全流程实施监测预警。 另外,应设置医疗机构的药品集中采购考核,其中对于协议完成率、30天汇款率、药占比、非中选产品采购量及金额占比、违规采购行为等进行了重点评分规定。

Developing evaluating systems of drug pricing and bidding and procurement performence

November 24th, 2020 | by

On September 16th, the NHSA offically issued the “Guidelines on Establishing a Evaluating System of Drug Pricing and Bidding and Procurement Performence,” which stipulates that each province should establish and launch their own system before the end of 2020. The “Guidelines” clarifies that centralised procurement organizations of drugs and medical equipments should prevent pharmaceutical companies from fixing unreasonable drug price, such as via giving kickback to hospitals. At the meantime, the pharmaceutical companies that do not act properly will be documented and punished according to different levels of dishonesty while they are also encouraged to rectify to regain their credit score.

医保局:医药价格和招采信用评价年底前落地!

来源:医药网  2020.09.17

9月16日,国家医保局官网正式发布了《关于建立医药价格和招采信用评价制度的指导意见》(以下简称《意见》),要求各地于2020年底前建立并实施医药价格和招采信用评价制度。《意见》明确,药品和医用耗材集中采购机构应采取措施制止医药企业给予回扣等不合理定价行为。同时,应记录失信医药企业信息,根据不同失信等级采取不同处置措施,并鼓励企业整改,主动修复信用。

Pharmacies can only rise the price of drug in the reimbursement list by 15%

November 24th, 2020 | by

On September 1st, the “Reform Project on Improving the Functions of the Centralised Drug Procurement Platform and Promoting a Full Coverage of Payment Requirement of Drugs on the Reimbursement List in Zhejiang Province” was implemented. The “Project” indicates that drugs included in the list of online transactions on the provincal procurement platform of drugs and medical equipments are included in the provincal drug reimbursement list. Designated public medical institutions and private medical institutions should fix the drug price that accords with the price on the drug reimbursement list while designated retailed pharmacies can rise the price upto 15% based on the price on the list.

9月1日起执行医保用药 药店只能加价15%

来源医药网  2020.09.03

9月1日,《浙江省提升药品集中采购平台功能推进医保药品支付标准全覆盖改革方案》正式实施。《方案》明确,所有纳入该省药械采购平台在线交易的医保目录内药品均纳入医保支付范围。其中,定点公立医疗机构与民营医疗机构医保药品执行相同的支付标准,定点零售药店医保支付标准统一按医疗机构支付标准上浮15%

Wuhan: implementing the centralised procurement of the intensive monitoring drugs

November 24th, 2020 | by

On August 6th, the Joint Procurement Office of Drugs and Medical Equipments in Wuhan issued the first “Price List of Intensive Monitoring Drugs” and implemented the centralised procurement of 30 sorts of intensive monitoring drugs, which will last one year and is aimed to regulate a rational drug pricing and guiding medical institutions to regulate medication to reduce the financial burden on patients.

武汉市启动30种重点监控药品集中议价采购

来源医药网  2020.08.06

8月6日,武汉市药械联合采购办公室公布武汉市首批《重点监控合理用药药品议价目录》,并正式启动武汉市30种重点监控药品集中议价采购周期为一年,旨在促进药价合理形成,引导医疗机构规范用药,切实减轻患者药费负担。

Price management in medical institutions

June 19th, 2020 | by

On January 2nd, the National Health Commission issued the “Standard of Price Management in Medical Institutions,” which will come into effect as the date of promulgation. The “Standard” indicates that medical institutions should establish a price management system that is consisted of several departments. Besides, the “Standard” stipulates that medical institutions should make several staffs supervise the medical costs and adjust unreasonable charges. Besides, medical institutions should establish a system that can analyze and manage the medical service cost and make the costs of common medical services public.

 

国家卫健委:医疗机构内部价格行为管理规定

来源:医药网  2020.01.06

1月2日,国家卫健委发布《医疗机构内部价格行为管理规定》,并将自发布之日起施行。《规定》提出,各医疗机构应到建立由多部门组成的价格管理体系。《规定》要求,医疗机构应配备一定数量医疗服务价格工作人员,用于定期检查患者花费,纠正医院不规范收费;各医疗机构应建立医疗服务成本测算和成本控制管理制度,同时公示常用医疗服务项目的价格。

Deepening the reform of the medical and health care system

May 31st, 2020 | by

On February 25th, the State Council issued the “Opinions on Deepening the Reform of the Medical and Health Care System.” The “Opinion” stipulates that medical institutions should improve the management of drug reimbursement lists, medical service protocols, and medicare settlement or increase the efficiency of medicare payment. Besides, the use of medical insurance funds should be strictly supervised, and insurance fraud will be dealt with according to legislation. In addition, the reform of centralized drug procurement should be deepened, and a pricing system that depends on the market should be established. Moreover, medical institutions should improve their service capacity and standardize new medical services, such as consulting over the internet.

 

关于深化医疗保障制度改革的意见

来源:医药网  2020.03.06

2月25日,国务院发布《关于深化医疗保障制度改革的意见》。《意见》要求,应完善医保目录、协议、结算管理,提升医保支付效率;完善医保基金监管,依法追究欺诈骗保行为;深化药品集中带量采购制度改革,并建立以市场为主导的药品价格形成机制;增强医疗服务能力,规范“互联网+医疗”等新服务模式发展。

 

 

Supervising the drug price and investigating the cost price

May 27th, 2020 | by

On December 6th, the National Medical Insurance Bureau issued the “Opinions on Supervising the Drug Price.” The “Opinion” indicated that a pricing system that depends on the market should be encouraged, and the centralised procurement with defined quantities, of which the drug price depends on the quantities and the bidding process combines with the procurement, should be further implemented. The “Opinion” also stipulated that a pre-warning system of abnormal drug price movements and an investigation system of the cost price of drugs should be established as well.

国家医保局发布文件:监管药品价格 调查成本

来源:医药网 2019.12.09

12月6日,国家医保局发布《关于做好当前药品价格管理工作的意见》(以下简称《意见》)。《意见》指出,坚持市场调节药品价格的总体方向;坚持“带量采购、量价挂钩、招采合一”的方针。《意见》要求,应建立价格供应异常变动监测预警机制,并完善药品价格成本调查工作机制。

 

Establishing a nationwide unified procurement platform of drugs

May 27th, 2020 | by

On November 29th, the National Health Commission issued the “Notification on Measures of Deepening the Reform of the Medical and Healthcare System depending on the Centralised Procurement and Use of Drugs.” The “Notification” emphasised that a nationwide unified procurement platform based on provincial centralised procurement platforms should be established, in which the drug codes and procurement standards should be unified so that the drug price can be linked together nationwide. In addition, corporate groups, integrated healthcare organisations, private medical institutions, and pharmacies are encouraged to implement centralised procurement to develop a pricing system that depends on the market. The “Notification” also stipulated that the medical insurance administrative agencies instead of hospitals should pay for the drugs to manufacturers and distributors directly.

医药行业变革:建设全国采购平台 全国价格联动

来源:医药网 2019.12.02

11月29日,国家卫健委体制改革司发布《国务院深化医药卫生改革领导小组印发关于以药品集中采购和使用为突破口进一步深化医药卫生体制改革若干政策措施的通知》。《通知》强调,应依托省级集中采购平台构建全国公共采购市场,统一编码、标准和功能规范,推进价格等相关信息互联互通,促进全国价格联动;鼓励探索集团采购、医联体采购等方式形成合理价格,鼓励非公立医疗机构、社会药店等积极参与,共同推动形成以市场为主导的药品价格形成机制;《通知》还要求,应由医保经办机构直接与生产或流通企业结算药品货款。

Nationwide implementation of National Organised Centralised Procurement and Use of Drugs

April 3rd, 2020 | by

On September 24th, 2019, more than 20 provinces and districts all over the country have launched a joint procurement of drugs. Thereby the pilot work on National Organised Centralised Procurement and Use of Drugs is extended from 11 big cities to nationwide. The price of all medicines was lower than the price of selected drugs in “4+7.”

医保局:国家组织药品集中采购和使用试点扩至全国

来源:医药网 2019.09.25

9月24日,全国二十多个省、区启动药品联合招标采购,国家组织药品集中采购和使用试点由11个城市扩大至全国。在此次扩围采购中,药品价格都降低到不高于此前11个试点城市中选价格的水平。

Health insurance: payment on the basis of sickness categories

May 4th, 2018 | by

Recently, the Ministry of Human Resources and Social Security published the recommended sickness catalog for the payment of health insurance on the basis of sickness categories. 130 kinds of sicknesses are included in the catalog. As requested, at least 100 sicknesses should be confirmed for the new payment method from place to place. The Ministry of Human Resources and Social Security also emphasized that unreasonable medical payment increases should be controlled to make sure the personal expenditure will not increase. (Source: Beijing Youth Daily)

医疗保险按病种付费病种推荐目录

来源:北京青年报 2018-02-28

核心提示: 人社部近日公布了医疗保险按病种付费病种推荐目录,130种疾病被列入目录。按照要求,各地应确定不少于100个病种开展按病种付费。人社部强调,控制不合理医疗费用增长,确保群众个人费用负担不增加。